AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Novartis AG Director's Dealing 2009

Aug 24, 2009

940_dirs_2009-08-24_784758ad-aa7a-4749-a3d4-f9b3f75e0a8e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDENIX PHARMACEUTICALS INC (IDIX)
CIK: 0001093649
Period of Report: 2009-08-21

Reporting Person: NOVARTIS AG (INDIRECT 10% OWNER)
Reporting Person: NOVARTIS PHARMA AG (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-08-21	Common Stock	P	3431	$2.41	Acquired	31320824	Indirect

Footnotes

F1: These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities. See attachment.